Thiadiazole compounds and use thereof

ABSTRACT

A thiadiazole compound of the formula (A): 
     
       
         
         
             
             
         
       
         
         wherein R 1  represents methyl, C3-C7 alkenyl, C2-C7 alkoxyalkyl, C2-C7 alkylthioalkyl, C4-C7 alkoxyalkoxyalkyl, C4-C7 alkylthioalkoxyalkyl, phenyl C1-C2 alkyl in which phenyl may be substituted, phenyloxy C1-C2 alkyl in which phenyloxy may be substituted, phenyl C2-C3 alkoxyalkyl in which phenyl may be substituted, or the substituent of the formula (B): 
       
    
     
       
         
         
             
             
         
       
         
         wherein R 3  represents C1-C3 alkyl, and R 4  represents a hydrogen atom, methyl, ethyl or phenyl which may be substituted; and 
         R 2  represents phenyl C1-C4 alkyl in which phenyl may be substituted, pyridyl C1-C4 alkyl in which pyridyl may be substituted, or pyrimidyl C1-C4 alkyl in which pyrimidyl may be substituted;
 
has an excellent arthropod pests controlling activity.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a section 371 national phase filing of InternationalApplication No. PCT/JP03/00237, filed Jan. 15, 2003, the disclosure ofwhich is incorporated herein by reference.

TECHNICAL FIELD OF THE INVENTION

The present invention relates to a thiadiazole and uses thereof.

BACKGROUND ART

It is known wherein a kind of thiadiazole compound can be used as anactive ingredient in an arthropod pests controlling composition (cf. DE3030661 publication).

However the arthropod pests controlling activity of the thiadiazolecompound is not efficient, then it is desired the compounds having moreefficient arthropod pests controlling activity.

DISCLOSURE OF THE INVENTION

The present inventor has earnestly studied, and found wherein athiadiazole compound of the formula (A) has excellent arthropod pestscontrolling activity to complete the present invention.

Namely, the present invention provides the thiadiazole compound(hereinafter, referred to as the present compound) of the formula (A):

-   wherein R¹ represents methyl, C3-C7 alkenyl, C2-C7 alkoxyalkyl,    C2-C7 alkylthioalkyl, C4-C7 alkoxyalkoxyalkyl, C4-C7    alkylthioalkoxyalkyl, phenyl C1-C2 alkyl in which phenyl may be    substituted, phenyloxy C1-C2 alkyl in which phenyloxy may be    substituted, phenyl C2-C3 alkoxyalkyl in which phenyl may be    substituted, or the substituent of the formula (B):

-   wherein R³ represents C1-C3 alkyl, and R⁴ represents a hydrogen    atom, methyl, ethyl or phenyl which may be substituted; and-   R² represents phenyl C1-C4 alkyl in which phenyl may be substituted,    pyridyl C1-C4 alkyl in which pyridyl may be substituted, or    pyrimidyl C1-C4 alkyl in which pyrimidyl may be substituted;-   the arthropod controlling composition comprising the present    compound as an active ingredients;    and the method for controlling an arthropod pest comprising applying    an effective amount of the present compound to an arthropod pest or    habitats of an arthropod pest.

In the present invention, each substituent represented by R¹ or R² isspecifically exemplified below.

The C3-C7 alkenyl, represented by R1, includes 2-butenyl,3-methyl-2-butenyl, 2-pentenyl and the like.

The C2-C6 alkoxyalkyl, represented by R1, includes (C1-C6 alkoxy)methyland the like; more specifically, methoxymethyl, ethoxymethyl,propoxymethyl, isopropoxymethyl and the like.

The C2-C7 alkylthioalkyl, represented by R1, includes (C1-C6alkylthio)methyl and the like; more specifically, methylthiomethyl,ethylthiomethyl, propylthiomethyl, isopropylthiomethyl and the like.

The C4-C7 alkoxyalkoxyalkyl, represented by R1, includes(2-methoxyethoxy)methyl and the like.

The C4-C7 alkylthioalkoxyalkyl, represented by R1, includes(2-ethylthioethoxy)methyl and the like.

The phenyl C1-C2 alkyl in which phenyl may be substituted, representedby R1, includes C1-C2 alkyl substituted with phenyl which may besubstituted with one or more selected from the group (hereinafter,referred to as the substitution group A) consisting of C1-C4 alkyl suchas methyl, ethyl, propyl, isopropyl, tert-butyl and the like; C1-C4haloalkyl such as trifluoromethyl, difluoromethyl, pentafluoroethyl andthe like; C1-C4 alkoxy such as methoxy, ethoxy, propoxy, isopropoxy andthe like; C1-C4 alkylthio such as methylthio, ethylthio and the like;C1-C4 haloalkoxy such as trifluoromethoxy, difluoromethoxy and the like;nitro; cyano; and halogen atoms such as a fluorine atom, chlorine atom,bromine atom and the like. More specifically it includes benzyl,2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 2-trifluoromethylbenzyl,3-trifluoromethylbenzyl, 4-trifluoromethylbenzyl, 2-methoxybenzyl,3-methoxybenzyl, 4-methoxybenzyl, 2-methylthiobenzyl,3-methylthiobenzyl, 4-methylthiobenzyl, 2-trifluoromethoxybenzyl,3-trifluoromethoxybenzyl, 4-trifluoromethoxybenzyl, 2-nitrobenzyl,3-nitrobenzyl, 4-nitrobenzyl, 2-cyanobenzyl, 3-cyanobenzyl,4-cyanobenzyl, 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl,3,4-difluorobenzyl, 3,5-difluorobenzyl, 2,6-difluorobenzyl,2,4-difluorobenzyl, 2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl,3,4-dichlorobenzyl, 3,5-dichlorobenzyl, 2,6-dichlorobenzyl,2,4-dichlorobenzyl, 2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl,3,4-dibromobenzyl, 3,5-dibromobenzyl, 2,6-dibromobenzyl,2,4-dibromobenzyl, 1-phenylethyl, 1-(2-methylphenyl)ethyl,1-(3-methylphenyl)ethyl, 1-(4-methylphenyl)ethyl,1-(2-trifluoromethylphenyl)ethyl, 1-(3-trifluoromethylphenyl)ethyl,1-(4-trifluoromethylphenyl)ethyl, 1-(2-methoxyphenyl)ethyl,1-(3-methoxyphenyl)ethyl, 1-(4-methoxyphenyl)ethyl,1-(2-methylthiophenyl)ethyl, 1-(3-methylthiophenyl)ethyl,1-(4-methylthiophenyl)ethyl, 1-(2-trifluoromethoxyphenyl)ethyl,1-(3-trifluoromethoxyphenyl)ethyl, 1-(4-trifluoromethoxyphenyl)ethyl,1-(2-nitrophenyl)ethyl, 1-(3-nitrophenyl)ethyl, 1-(4-nitrophenyl)ethyl,1-(2-cyanophenyl)ethyl, 1-(3-cyanophenyl)ethyl, 1-(4-cyanophenyl)ethyl,1-(2-fluorophenyl)ethyl, 1-(3-fluorophenyl)ethyl,1-(4-fluorophenyl)ethyl, 1-(3,4-difluorophenyl)ethyl,1-(3,5-difluorophenyl)ethyl, 1-(2,6-difluorophenyl)ethyl,1-(2,4-difluorophenyl)ethyl, 1-(2-chlorophenyl)ethyl,1-(3-chlorophenyl)ethyl, 1-(4-chlorophenyl)ethyl,1-(3,4-dichlorophenyl)ethyl, 1-(3,5-dichlorophenyl)ethyl,1-(2,6-dichlorophenyl)ethyl, 1-(2,4-dichlorophenyl)ethyl,1-(2-bromophenyl)ethyl, 1-(3-bromophenyl)ethyl, 1-(4-bromophenyl)ethyl,1-(3,4-dibromophenyl)ethyl, 1-(3,5-dibromophenyl)ethyl,1-(2,6-dibromophenyl)ethyl, 1-(2,4-dibromophenyl)ethyl, 2-phenylethyl,2-(2-methylphenyl)ethyl, 2-(3-methylphenyl)ethyl,2-(4-methylphenyl)ethyl, 2-(2-trifluoromethylphenyl)ethyl,2-(3-trifluoromethylphenyl)ethyl, 2-(4-trifluoromethylphenyl)ethyl,2-(2-methoxyphenyl)ethyl, 2-(3-methoxyphenyl)ethyl,2-(4-methoxyphenyl)ethyl, 2-(2-methylthiophenyl)ethyl,2-(3-methylthiophenyl)ethyl, 2-(4-methylthiophenyl)ethyl,2-(2-trifluoromethoxyphenyl)ethyl, 2-(3-trifluoromethoxyphenyl)ethyl,2-(4-trifluoromethoxyphenyl)ethyl, 2-(2-nitrophenyl)ethyl,2-(3-nitrophenyl)ethyl, 2-(4-nitrophenyl)ethyl, 2-(2-cyanophenyl)ethyl,2-(3-cyanophenyl)ethyl, 2-(4-cyanophenyl)ethyl, 2-(2-fluorophenyl)ethyl,2-(3-fluorophenyl)ethyl, 2-(4-fluorophenyl)ethyl,2-(3,4-difluorophenyl)ethyl, 2-(3,5-difluorophenyl)ethyl,2-(2,6-difluorophenyl)ethyl, 2-(2,4-difluorophenyl)ethyl,2-(2-chlorophenyl)ethyl, 2-(3-chlorophenyl)ethyl,2-(4-chlorophenyl)ethyl, 2-(3,4-dichlorophenyl)ethyl,2-(3,5-dichlorophenyl)ethyl, 2-(2,6-dichlorophenyl)ethyl,2-(2,4-dichlorophenyl)ethyl, 2-(2-bromophenyl)ethyl,2-(3-bromophenyl)ethyl, 2-(4-bromophenyl)ethyl,2-(3,4-dibromophenyl)ethyl, 2-(3,5-dibromophenyl)ethyl,2-(2,6-dibromophenyl)ethyl, 2-(2,4-dibromophenyl)ethyl and the like.

The phenoxy C1-C2 alkyl in which pheoxy may be substituted, representedby R1, includes C1-C2 alkyl substituted with phenoxy which may besubstituted with one or more selected from the substitution group A.More specifically it includes phenyloxymethyl, 1-(phenyloxy)ethyl,2-(phenyloxy)ethyl, (2-methylphenyl)oxymethyl,(3-methylphenyl)oxymethyl, (4-methylphenyl)oxymethyl,(2-trifluoromethylphenyl)oxymethyl, (3-trifluoromethylphenyl)oxymethyl,(4-trifluoromethylphenyl)oxymethyl, (2-methoxyphenyl)oxymethyl,(3-methoxyphenyl)oxymethyl, (4-methoxyphenyl)oxymethyl,(2-methylthiophenyl)oxymethyl, (3-methylthiophenyl)oxymethyl,(4-methylthiophenyl)oxymethyl, (2-trifluoromethoxyphenyl)oxymethyl,(3-trifluoromethoxyphenyl)oxymethyl,(4-trifluoromethoxyphenyl)oxymethyl, (2-nitrophenyl)oxymethyl,(3-nitrophenyl)oxymethyl, (4-nitrophenyl)oxymethyl,(2-cyanophenyl)oxymethyl, (3-cyanophenyl)oxymethyl,(4-cyanophenyl)oxymethyl, (2-fluorophenyl)oxymethyl,(3-fluorophenyl)oxymethyl, (4-fluorophenyl)oxymethyl,(3,4-difluorophenyl)oxymethyl, (3,5-difluorophenyl)oxymethyl,(2,6-difluorophenyl)oxymethyl, (2,4-difluorophenyl)oxymethyl,(2-chlorophenyl)oxymethyl, (3-chlorophenyl)oxymethyl,(4-chlorophenyl)oxymethyl, (3,4-dichlorophenyl)oxymethyl,(3,5-dichlorophenyl)oxymethyl, (2,6-dichlorophenyl)oxymethyl,(2,4-dichlorophenyl)oxymethyl, (2-bromophenyl)oxymethyl,(3-bromophenyl)oxymethyl, (4-bromophenyl)oxymethyl,(3,4-dibromophenyl)oxymethyl, (3,5-dibromophenyl)oxymethyl,(2,6-dibromophenyl)oxymethyl, (2,4-dibromophenyl)oxymethyl and the like.

The phenyl C2-C3 alkoxyalkyl in which phenyl may be substituted,represented by R1, includes C2-C3 alkoxyalkyl substituted with phenylwhich may be substituted with one or more selected from the substitutiongroup A. More specifically it includes benzyloxymethyl(2-methylbenzyl)oxymethyl, (3-methylbenzyl)oxymethyl,(4-methylbenzyl)oxymethyl, (2-trifluoromethylbenzyl)oxymethyl,(3-trifluoromethylbenzyl)oxymethyl, (4-trifluoromethylbenzyl)oxymethyl,(2-methoxybenzyl)oxymethyl, (3-methoxybenzyl)oxymethyl,(4-methoxybenzyl)oxymethyl, (2-methylthiobenzyl)oxymethyl,(3-methylthiobenzyl)oxymethyl, (4-methylthiobenzyl)oxymethyl,(2-trifluoromethoxybenzyl)oxymethyl,(3-trifluoromethoxybenzyl)oxymethyl,(4-trifluoromethoxybenzyl)oxymethyl, (2-nitrobenzyl)oxymethyl,(3-nitrobenzyl)oxymethyl, (4-nitrobenzyl)oxymethyl,(2-cyanobenzyl)oxymethyl, (3-cyanobenzyl)oxymethyl,(4-cyanobenzyl)oxymethyl, (2-fluorobenzyl)oxymethyl,(3-fluorobenzyl)oxymethyl, (4-fluorobenzyl)oxymethyl,(3,4-difluorobenzyl)oxymethyl, (3,5-difluorobenzyl)oxymethyl,(2,6-difluorobenzyl)oxymethyl, (2,4-difluorobenzyl)oxymethyl,(2-chlorobenzyl)oxymethyl, (3-chlorobenzyl)oxymethyl,(4-chlorobenzyl)oxymethyl, (3,4-dichlorobenzyl)oxymethyl,(3,5-dichlorobenzyl)oxymethyl, (2,6-dichlorobenzyl)oxymethyl,(2,4-dichlorobenzyl)oxymethyl, (2-bromobenzyl)oxymethyl,(3-bromobenzyl)oxymethyl, (4-bromobenzyl)oxymethyl,(3,4-dibromobenzyl)oxymethyl, (3,5-dibromobenzyl)oxymethyl,(2,6-dibromobenzyl)oxymethyl, (2,4-dibromobenzyl)oxymethyl and the like.

The substituent of the formula (B), represented by R1, includes thesubstituent wherein R³ is C1-C3 alkyl and R⁴ is a hydrogen atom, thesubstituent wherein R³ is C1-C3 alkyl and R⁴ is phenyl which may besubstituted with one or more selected from the substitution group A, andthe like; more specifically, acetoxymethyl, α-acetyloxybenzyl and thelike.

The phenyl C1-C4 alkyl in which phenyl may be substitued, represented byR2, includes C1-C4 alkyl substituted with phenyl which may besubstituted with one or more selected from the substitution group A;more specifically, benzyl, 4-halogenobenzyl, 3-halogenobenzyl,4-trifluoromethylbenzyl, 3-trifluoromethylbenzyl,4-trifluoromethoxybenzyl, 3-trifluoromethoxybenzyl,3,4-dihalogenobenzyl, 3,5-dihalogenobenzyl, 2,6-dihalogenobenzyl,1-phenylethyl, 1-(fluorophenyl)ethyl, 1-(chlorophenyl)ethyl,1-phenylpropyl, 2-phenylethyl, 2-(fluorophenyl)ethyl,2-(chlorophenyl)ethyl, 3-phenylpropyl and the like.

The pyridyl C1-C4 alkyl in which pyridyl may be substituted, representedby R2, includes C1-C4 alkyl substituted with 2-pyridyl, 3-pyridyl or4-pyridyl which may be substituted with one or more selected from thesubstitution group A; more specifically, (2-pyridyl)methyl,(3-pyridyl)methyl, (4-pyridyl)methyl, 1-(2-pyridyl)ethyl,1-(3-pyridyl)ethyl, 1-(4-pyridyl)ethyl, 2-(2-pyridyl)ethyl,2-(3-pyridyl)ethyl, 2-(4-pyridyl)ethyl, (6-chloro-2-pyridyl)methyl andthe like.

The pyrimidyl C1-C4 alkyl in which pyrimidyl may be substituted,represented by R2, includes C1-C4 alkyl substituted with 2-pyrimidyl,4-pyrimidyl or 5-pyrimidyl which may be substituted with one or moreselected from the substitution group A; more specifically,(2-pyrimidyl)methyl, (4-pyrimidyl)methyl, (5-pyrimidyl)methyl and thelike.

Embodiments of the present compound include, for example, the followingcompounds:

-   the thiadiazole compound wherein R¹ is methyl in the formula (A);-   the thiadiazole compound wherein R¹ is C3-C7 alkenyl, C2-C7    alkoxyalkyl, C2-C7 alkylthioalkyl, C4-C7 alkoxyalkoxyalkyl or C4-C7    alkylthioalkoxyalkyl in the formula (A);-   the thiadiazole compound wherein R¹ is the C3-C7 alkenyl which has    double bond at the 2-position in the formula (A);-   the thiadiazole compound wherein R¹ is allyl in the formula (A);-   the thiadiazole compound wherein R¹ is (C1-C6 alkoxy)methyl or    (C1-C6 alkylthio)methyl in the formula (A);-   the thiadiazole compound wherein R¹ is methoxymethyl in the formula    (A);-   the thiadiazole compound wherein R¹ is ethoxymethyl in the formula    (A);-   the thiadiazole compound wherein R¹ is methoxyethoxymethyl in the    formula (A);-   the thiadiazole compound wherein R¹ is phenyl C1-C2 alkyl in which    phenyl may be substituted with one or more selected from the    substitution group A, phenyloxy C1-C2 alkyl in which phenyloxy may    be substituted with one or more selected from the substitution group    A, or phenyl C2-C3 alkoxyalkyl in which phenyl may be substituted    with one or more selected from the substitution group A in the    formula (A);-   the thiadiazole compound wherein R¹ is benzyl which may be    substituted with one or more selected from the substitution group A,    phenyloxymethyl which may be substituted with one or more selected    from the substitution group A, or benzyloxymethyl which may be    substituted with one or more selected from the substitution group A    in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with (a)    halogen atom(s) in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with (a)    fluorine atom(s) in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with (a)    chlorine atom(s) in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with    methyl in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with    methoxy in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with    trifluoromethyls at one or two places in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl substituted with    trifluoromethoxy at one place in the formula (A);-   the thiadiazole compound wherein R¹ is benzyloxymethyl in the    formula (A);-   the thiadiazole compound wherein R¹ is acetoxymethyl in the formula    (A);-   the thiadiazole compound wherein R² is phenyl C1-C4 alkyl in which    the phenyl may be substituted with one or more selected from the    substitution group A, pyridyl C1-C4 alkyl in which the pyridyl may    be substituted with one or more selected from the substitution group    A, or pyrimidyl C1-C4 alkyl in which the pyrimidyl may be    substituted with one or more selected from the substitution group A    in the formula (A);-   the thiadiazole compound wherein R² is phenyl C1-C4 alkyl in which    the phenyl may be substituted with one or more selected from the    group (hereinafter, referred to as the substitution group B)    consisting of C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C1-C4    alkylthio, C1-C4 haloalkoxy and halogen atoms, pyridyl C1-C4 alkyl    in which the pyridyl may be substituted with one or more selected    from the substitution group B, or pyrimidyl C1-C4 alkyl in which the    pyrimidyl may be substituted with one or more selected from the    substitution group B in the formula (A);-   the thiadiazole compound wherein R² is phenyl C1-C4 alkyl in which    the phenyl may be substituted with one or more selected from the    substitution group B, or pyridyl C1-C4 alkyl in which the pyridyl    may be substituted with one or more selected from the substitution    group B in the formula (A);-   the thiadiazole compound wherein R² is benzyl in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with (a)    halogen atom(s) in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with (a)    fluorine atom(s) in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with (a)    chlorine atom(s) in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with (a)    bromine atom(s) in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with (a)    iodine atom(s) in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with    methyl in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with    trifluoromethyls at one or two places in the formula (A);-   the thiadiazole compound wherein R² is benzyl substituted with    trifluoromethoxy at one place in the formula (A);-   the thiadiazole compound wherein R² is 1-phenylethyl in the formula    (A);-   the thiadiazole compound wherein R² is 1-phenylethyl in which the    phenyl is substituted with a fluorine atom or a chlorine atom at one    place in the formula (A);-   the thiadiazole compound wherein R² is 1-phenylpropyl in the formula    (A);-   the thiadiazole compound wherein R² is 2-phenylethyl in which the    phenyl is substituted with a fluorine atom or chlorine atom at one    place in the formula (A);-   the thiadiazole compound wherein R² is 3-phenylpropyl in the formula    (A);-   the thiadiazole compound wherein R² is pyridylmethyl in the formula    (A);-   the thiadiazole compound wherein R² is pyridylmethyl in which the    pyridyl is substituted with a fluorine atom at one place in the    formula (A);-   the thiadiazole compound wherein R² is pyridylmethyl in which the    pyridyl is substituted with a chlorine atom at one place in the    formula (A);-   the thiadiazole compound wherein R² is 2-pyridylmethyl substituted    with a fluorine or chlorine atom at 6-position in the formula (A);-   the thiadiazole compound wherein R² is 2-(2-pyridyl)ethyl in the    formula (A);-   the thiadiazole compound wherein R² is 2-(3-pyridyl)ethyl in the    formula (A);-   the thiadiazole compound wherein R² is 2-(4-pyridyl)ethyl in the    formula (A);-   the thiadiazole compound wherein R² is pyrimidylmethyl in the    formula (A);-   the thiadiazole compound wherein R² is 2-pyrimidylmethyl in the    formula (A);-   the thiadiazole compound wherein R² is 4-pyrimidylmethyl in the    formula (A);-   the thiadiazole compound wherein R² is 5-pyrimidylmethyl in the    formula (A);-   the thiadiazole compound wherein R¹ is methyl, and R² is phenyl    C1-C4 alkyl in which the phenyl may be substituted, pyridyl C1-C4    alkyl in which the pyridyl may be substituted, or pyrimidyl C1-C4    alkyl in which the pyrimidyl may be substituted in the formula (A);-   the thiadiazole compound wherein R¹ is methyl, and R² is phenyl    C1-C4 alkyl in which the phenyl may be substituted, or pyridyl C1-C4    alkyl in which the pyridyl may be substituted in the formula (A);-   the thiadiazole compound wherein R¹ is methyl, and R² is phenyl    C1-C4 alkyl in which the phenyl may be substituted with one or more    selected from the substitution group A, pyridyl C1-C4 alkyl in which    the pyridyl may be substituted with one or more selected from the    substitution group A, or pyrimidyl C1-C4 alkyl in which the    pyrimidyl may be substituted with one or more selected from the    substitution group A in the formula (A);-   the thiadiazole compound wherein R¹ is methyl, and R² is phenyl    C1-C4 alkyl in which the phenyl may be substituted with one or more    selected from the substitution group A, or pyridyl C1-C4 alkyl in    which the pyridyl may be substituted with one or more selected from    the substitution group A in the formula (A);-   the thiadiazole compound wherein R¹ is C3-C7 alkenyl, C2-C7    alkoxyalkyl, C2-C7 alkylthioalkyl, C4-C7 alkoxyalkoxyalkyl or C4-C7    alkylthioalkoxyalkyl, and R² is phenyl C1-C4 alkyl in which the    phenyl may be substituted with one or more selected from the    substitution group A, pyridyl C1-C4 alkyl in which the pyridyl may    be substituted with one or more selected from the substitution group    A, or pyrimidyl C1-C4 alkyl in which the pyrimidyl may be    substituted with one or more selected from the substitution group A    in the formula (A);-   the thiadiazole compound wherein R¹ is phenyl C1-C2 alkyl in which    phenyl may be substituted with one or more selected from the    substitution group A, phenyloxy C1-C2 alkyl in which phenyloxy may    be substituted with one or more selected from the substitution group    A, or phenyl C2-C3 alkoxyalkyl in which phenyl may be substituted    with one or more selected from the substitution group A, and R² is    phenyl C1-C4 alkyl in which the phenyl may be substituted with one    or more selected from the substitution group A, pyridyl C1-C4 alkyl    in which the pyridyl may be substituted with one or more selected    from the substitution group A, or pyrimidyl C1-C4 alkyl in which the    pyrimidyl may be substituted with one or more selected from the    substitution group A in the formula (A);-   the thiadiazole compound wherein R¹ is (C1-C6 alkoxy)methyl or    (C1-C6 alkylthi)methyl, and R² is phenyl C1-C4 alkyl in which the    phenyl may be substituted with one or more selected from the    substitution group A, pyridyl C1-C4 alkyl in which the pyridyl may    be substituted with one or more selected from the substitution group    A, or pyrimidyl C1-C4 alkyl in which the pyrimidyl may be    substituted with one or more selected from the substitution group A    in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl which may be    substituted with one or more selected from the substitution group A,    phenyloxymethyl which may be substituted with one or more selected    from the substitution group A, or benzyloxymethyl which may be    substituted with one or more selected from the substitution group A,    and R² is phenyl C1-C4 alkyl in which the phenyl may be substituted    with one or more selected from the substitution group A, pyridyl    C1-C4 alkyl in which the pyridyl may be substituted with one or more    selected from the substitution group A, or pyrimidyl C1-C4 alkyl in    which the pyrimidyl may be substituted with one or more selected    from the substitution group A in the formula (A);-   the thiadiazole compound wherein R¹ is methyl, and R² is benzyl    which may be substituted with (a) halogen atom(s) in the formula    (A);-   the thiadiazole compound wherein R¹ is C3-C7 alkenyl, C2-C7    alkoxyalkyl, C2-C7 alkylthioalkyl, C4-C7 alkoxyalkoxyalkyl, or C4-C7    alkylthioalkoxyalkyl, and R² is benzyl substituted with a halogen    atom in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl which may be    substituted with one or more selected from the substitution group A,    phenyloxymethyl which may be substituted with one or more selected    from the substitution group A, or benzyloxymethyl which may be    substituted with one or more selected from the substitution group A,    and R² is benzyl substituted with a halogen atom in the formula (A);-   the thiadiazole compound wherein R¹ is benzyl, and R² is benzyl    substituted with a halogen atom in the formula (A).

The following will describe a production process for the presentcompounds.

In the present compound, the compound wherein R¹ is methy, C3-C7alkenyl, C2-C7 alkoxyalkyl, C2-C7 alkylthioalkyl, C4-C7alkoxyalkoxyalkyl, C4-C7 alkylthioalkoxyalkyl, phenyl C1-C2 alkyl inwhich phenyl may be substituted, phenyloxy C1-C2 alkyl in whichphenyloxy may be substituted, phenyl C2-C3 alkoxyalkyl in which phenylmay be substituted, namely the compound of the formula (A-1), can beproduced, for example, by making a 5-chloro-1,2,4-thiadiazole compoundof the formula (I) react with an alcohol compound of the formula (II).

wherein R¹¹ is methy, C3-C7 alkenyl, C2-C7 alkoxyalkyl, C2-C7alkylthioalkyl, C4-C7 alkoxyalkoxyalkyl, C4-C7 alkylthioalkoxyalkyl,phenyl C1-C2 alkyl in which phenyl may be substituted, phenyloxy C1-C2alkyl in which phenyloxy may be substituted, phenyl C2-C3 alkoxyalkyl inwhich phenyl may be substituted, and R² has the same meaning asdescribed above.

The reaction is generally carried out in the presence of base in asolvent. The solvent to be used in the reaction includes, for example,aliphatic hydrocarbons such as hexane, heptane, octane and the like;aromatic hydrocarbons such as toluene, xylene and the like; ethers suchas tetrahydrofuran, 1,4-dioxane, methyl tert-butyl ether,1,2-dimethoxyethane and the like; acid amides such asN,N-dimethylformamide and the like, and mixtures thereof. The base to beused in the reaction includes, for example, inorganic base such assodium hydride, potassium carbonate and the like. Concerning the amountof the reagents, the amount of the alcohol compound of the formula (II)is usually 1 to 1.5 mole based on 1 mole of the5-chloro-1,2,4-thiadiazole compound of the formula (I), and the amountof the base is usually 1 to 1.5 mole based on 1 mole of the alcoholcompound of the formula (II). The reaction temperature is usually in therange of −20° C. to 80° C., and the reaction time is usually in therange of 0.5 to 24 hours.

After completion of the reaction, the present compound of the formula(A-1) can be isolated by subjecting the reaction mixture topost-treatment such as adding the reaction mixture into water,extracting with an organic solvent, drying and concentrating the organicphase obtained and the like. The isolated present compound of theformula (A-1) can be purified by a technique such as chromatography,recrystallization and the like, if necessary.

In the present compound, the compound wherein R¹ is the group of theformula (B), namely the compound of the formula (A-2), can be produced,for example, by making the thiadiazole compound of the formula (III)react with an oxidizing reagent to obtain the sulfoxide compound of theformula (IV) (hereinafter, referred to as Step 1), and making thesulfoxide compound of the formula (IV) react with the acid anhydride ofthe formula (V) (hereinafter, referred to as Step 2).

wherein R², R³ and R⁴ have the same meaning as described above.Step 1

The reaction is generally carried out in a solvent. The solvent to beused in the reaction includes, for example, halogenated aliphatichydrocarbons such as dichloromethane, chloroform and the like.

The oxidizing reagent to be used in the reaction includes, for example,peracid such as 2-chloro perbenzoic acid and the like. The amount of theoxidizing reagent to be used in the reaction is usually 1 to 1.5 molebased on 1 mole of the thiadiazole compound of the formula (III). Thereaction temperature is usually in the range of −20° C. to 30° C., andthe reaction time is usually in the range of momentary to 24 hours.

After completion of the reaction, the sulfoxide compound of the formula(IV) can be isolated by subjecting the reaction mixture topost-treatment such as adding the reaction mixture into water,extracting with an organic solvent, if necessary washing the organicphase with an aqueous solution of reducing reagent such as sodiumsulfite, sodium thiosulfate and the like, drying and concentrating theorganic phase obtained and the like. The isolated sulfoxide compound ofthe formula (IV) can be purified by a technique such as chromatography,recrystallization and the like.

Step 2

The reaction is carried out by making the sulfoxide compound of theformula (IV) react with the acid anhydride of the formula (V), andgenerally carried out in the presence of base, and may be carried out ina solvent. The base to be used in the reaction includes, for example,pyridines such as 2,6-lutidine and the like, and alkali metal salt ofacetic acid such as sodium acetate and the like.

Concerning the amount of the reagents, the amount of the acid anhydrideof the formula (V) is usually 1 to 50 moles and the amount of the baseis 1 to 10 moles, based on 1 mole of the sulfoxide compound of theformula (IV).

The reaction temperature is usually in the range of 0° C. to 150° C.,and the reaction time is usually in the range of 1 to 72 hours.

After completion of the reaction, the present compound of the formula(A-2) can be isolated by subjecting the reaction mixture topost-treatment such as adding the reaction mixture into an aqueoussolution of sodium hydrogen carbonate and the like, extracting with anorganic solvent, drying and concentrating the organic phase obtained andthe like. The isolated present compound of the formula (A-2) can bepurified by a technique such as chromatography, recrystallization andthe like.

The compound of the formula (I) can be produced, for example, by themethod described in Chem. Ber. 90, 892 (1957).

Next, examples of the present compound are shown.

The compound wherein the R¹ in the formula (i) is the substituentdescribed below.

-   -   Methyl; allyl, 2-butenyl, 3-methyl-2-butenyl, 2-pentenyl;        methoxymethyl, ethoxymethyl, propoxymethyl, isopropoxymethyl,        butoxymethyl, isobutoxymethyl, sec-butoxymethyl,        tert-butoxymethyl; methylthiomethyl, ethylthiomethyl,        propylthiomethyl, isopropylthiomethyl; (methoxyethoxy)methyl,        (ethoxyethoxy)methyl; (methylthioethoxy)methyl; benzyl,        2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl,        2-trifluoromethylbenzyl, 3-trifluoromethylbenzyl,        4-trifluoromethylbenzyl, 2-methoxybenzyl, 3-methoxybenzyl,        4-methoxybenzyl, 2-methylthiobenzyl, 3-methylthiobenzyl,        4-methylthiobenzyl, 2-trifluoromethoxybenzyl,        3-trifluoromethoxybenzyl, 4-trifluoromethoxybenzyl,        2-nitrobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2-cyanobenzyl,        3-cyanobenzyl, 4-cyanobenzyl, 2-fluorobenzyl, 3-fluorobenzyl,        4-fluorobenzyl, 3,4-difluorobenzyl, 3,5-difluorobenzyl,        2,6-difluorobenzyl, 2,4-difluorobenzyl, 2-chlorobenzyl,        3-chlorobenzyl, 4-chlorobenzyl, 3,4-dichlorobenzyl,        3,5-dichlorobenzyl, 2,6-dichlorobenzyl, 2,4-dichlorobenzyl,        2-bromobenzyl, 3-bromobenzyl, 4-bromobenzyl, 3,4-dibromobenzyl,        3,5-dibromobenzyl, 2,6-dibromobenzyl, 2,4-dibromobenzyl,        1-phenylethyl, 1-(2-methylphenyl)ethyl, 1-(3-methylphenyl)ethyl,        1-(4-methylphenyl)ethyl, 1-(2-trifluoromethylphenyl)ethyl,        1-(3-trifluoromethylphenyl)ethyl,        1-(4-trifluoromethylphenyl)ethyl, 1-(2-methoxyphenyl)ethyl,        1-(3-methoxyphenyl)ethyl, 1-(4-methoxyphenyl)ethyl,        1-(2-methylthiophenyl)ethyl, 1-(3-methylthiophenyl)ethyl,        1-(4-methylthiophenyl)ethyl, 1-(2-trifluoromethoxyphenyl)ethyl,        1-(3-trifluoromethoxyphenyl)ethyl,        1-(4-trifluoromethoxyphenyl)ethyl, 1-(2-nitrophenyl)ethyl,        1-(3-nitrophenyl)ethyl, 1-(4-nitrophenyl)ethyl,        1-(2-cyanophenyl)ethyl, 1-(3-cyanophenyl)ethyl,        1-(4-cyanophenyl)ethyl, 1-(2-fluorophenyl)ethyl,        1-(3-fluorophenyl)ethyl, 1-(4-fluorophenyl)ethyl,        1-(3,4-difluorophenyl)ethyl, 1-(3,5-difluorophenyl)ethyl,        1-(2,6-difluorophenyl)ethyl, 1-(2,4-difluorophenyl)ethyl,        1-(2-chlorophenyl)ethyl, 1-(3-chlorophenyl)ethyl,        1-(4-chlorophenyl)ethyl, 1-(3,4-dichlorophenyl)ethyl,        1-(3,5-dichlorophenyl)ethyl, 1-(2,6-dichlorophenyl)ethyl,        1-(2,4-dichlorophenyl)ethyl, 1-(2-bromophenyl)ethyl,        1-(3-bromophenyl)ethyl, 1-(4-bromophenyl)ethyl,        1-(3,4-dibromophenyl)ethyl, 1-(3,5-dibromophenyl)ethyl,        1-(2,6-dibromophenyl)ethyl, 1-(2,4-dibromophenyl)ethyl,        2-phenylethyl, 2-(2-methylphenyl)ethyl, 2-(3-methylphenyl)ethyl,        2-(4-methylphenyl)ethyl, 2-(2-trifluoromethylphenyl)ethyl,        2-(3-trifluoromethylphenyl)ethyl,        2-(4-trifluoromethylphenyl)ethyl, 2-(2-methoxyphenyl)ethyl,        2-(3-methoxyphenyl)ethyl, 2-(4-methoxyphenyl)ethyl,        2-(2-methylthiophenyl)ethyl 2-(3-methylthiophenyl)ethyl,        2-(4-methylthiophenyl)ethyl, 2-(2-trifluoromethoxyphenyl)ethyl,        2-(3-trifluoromethoxyphenyl)ethyl,        2-(4-trifluoromethoxyphenyl)ethyl, 2-(2-nitrophenyl)ethyl,        2-(3-nitrophenyl)ethyl, 2-(4-nitrophenyl)ethyl,        2-(2-cyanophenyl)ethyl, 2-(3-cyanophenyl)ethyl,        2-(4-cyanophenyl)ethyl, 2-(2-fluorophenyl)ethyl,        2-(3-fluorophenyl)ethyl, 2-(4-fluorophenyl)ethyl,        2-(3,4-difluorophenyl)ethyl, 2-(3,5-difluorophenyl)ethyl,        2-(2,6-difluorophenyl)ethyl, 2-(2,4-difluorophenyl)ethyl,        2-(2-chlorophenyl)ethyl, 2-(3-chlorophenyl)ethyl,        2-(4-chlorophenyl)ethyl, 2-(3,4-dichlorophenyl)ethyl,        2-(3,5-dichlorophenyl)ethyl, 2-(2,6-dichlorophenyl)ethyl,        2-(2,4-dichlorophenyl)ethyl, 2-(2-bromophenyl)ethyl,        2-(3-bromophenyl)ethyl, 2-(4-bromophenyl)ethyl, 2-(3,4-dibromo        phenyl)ethyl, 2-(3,5-dibromophenyl)ethyl,        2-(2,6-dibromophenyl)ethyl, 2-(2,4-dibromophenyl)ethyl;        phenyloxymethyl, 1-(phenyloxy)ethyl, 2-(phenyloxy)ethyl        (2-methylphenyl)oxymethyl, (3-methylphenyl)oxymethyl,        (4-methylphenyl)oxymethyl, (2-trifluoromethylphenyl)oxymethyl,        (3-trifluoromethylphenyl)oxymethyl,        (4-trifluoromethylphenyl)oxymethyl, (2-methoxyphenyl)oxymethyl,        (3-methoxyphenyl)oxymethyl, (4-methoxyphenyl)oxymethyl,        (2-methylthiophenyl)oxymethyl, (3-methylthiophenyl)oxymethyl,        (4-methylthiophenyl)oxymethyl,        (2-trifluoromethoxyphenyl)oxymethyl,        (3-trifluoromethoxyphenyl)oxymethyl,        (4-trifluoromethoxyphenyl)oxymethyl, (2-nitrophenyl)oxymethyl,        (3-nitrophenyl)oxymethyl, (4-nitrophenyl)oxymethyl,        (2-cyanophenyl)oxymethyl, (3-cyanophenyl)oxymethyl,        (4-cyanophenyl)oxymethyl, (2-fluorophenyl)oxymethyl,        (3-fluorophenyl)oxymethyl, (4-fluorophenyl)oxymethyl,        (3,4-difluorophenyl)oxymethyl, (3,5-difluorophenyl)oxymethyl,        (2,6-difluorophenyl)oxymethyl, (2,4-difluorophenyl)oxymethyl,        (2-chlorophenyl)oxymethyl, (3-chlorophenyl)oxymethyl,        (4-chlorophenyl)oxymethyl, (3,4-dichlorophenyl)oxymethyl,        (3,5-dichlorophenyl)oxymethyl, (2,6-dichlorophenyl)oxymethyl,        (2,4-dichlorophenyl)oxymethyl, (2-bromophenyl)oxymethyl,        (3-bromophenyl)oxymethyl, (4-bromophenyl)oxymethyl,        (3,4-dibromophenyl)oxymethyl, (3,5-dibromophenyl)oxymethyl,        (2,6-dibromophenyl)oxymethyl, (2,4-dibromophenyl)oxymethyl;        benzyloxymethyl, (2-methylbenzyl)oxymethyl,        (3-methylbenzyl)oxymethyl, (4-methylbenzyl)oxymethyl,        (2-trifluoromethylbenzyl)oxymethyl,        (3-trifluoromethylbenzyl)oxymethyl,        (4-trifluoromethylbenzyl)oxymethyl, (2-methoxybenzyl)oxymethyl,        (3-methoxybenzyl)oxymethyl, (4-methoxybenzyl)oxymethyl,        (2-methylthiobenzyl)oxymethyl, (3-methylthiobenzyl)oxymethyl,        (4-methylthiobenzyl)oxymethyl,        (2-trifluoromethoxybenzyl)oxymethyl,        (3-trifluoromethoxybenzyl)oxymethyl,        (4-trifluoromethoxybenzyl)oxymethyl, (2-nitrobenzyl)oxymethyl,        (3-nitrobenzyl)oxymethyl, (4-nitrobenzyl)oxymethyl,        (2-cyanobenzyl)oxymethyl, (3-cyanobenzyl)oxymethyl,        (4-cyanobenzyl)oxymethyl, (2-fluorobenzyl)oxymethyl,        (3-fluorobenzyl)oxymethyl, (4-fluorobenzyl)oxymethyl,        (3,4-difluorobenzyl)oxymethyl, (3,5-difluorobenzyl)oxymethyl,        (2,6-difluorobenzyl)oxymethyl, (2,4-difluorobenzyl)oxymethyl,        (2-chlorobenzyl)oxymethyl, (3-chlorobenzyl)oxymethyl,        (4-chlorobenzyl)oxymethyl, (3,4-dichlorobenzyl)oxymethyl,        (3,5-dichlorobenzyl)oxymethyl, (2,6-dichlorobenzyl)oxymethyl,        (2,4-dichlorobenzyl)oxymethyl, (2-bromobenzyl)oxymethyl,        (3-bromobenzyl)oxymethyl, (4-bromobenzyl)oxymethyl,        (3,4-dibromobenzyl)oxymethyl, (3,5-dibromobenzyl)oxymethyl,        (2,6-dibromobenzyl)oxymethyl, (2,4-dibromobenzyl)oxymethyl;        acetyloxymethyl, propionyloxymethyl, α-acetoxybenzyl.

The compound wherein the R¹ in the formula (ii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (ii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (iii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (iv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (v) is the substituentdescribed above.

The compound wherein the R¹ in the formula (vi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (vii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (viii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (ix) is the substituentdescribed above.

The compound wherein the R¹ in the formula (x) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xiii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xiv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xvi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xvii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xviii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xix) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xx) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxiii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxiv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxvi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxvii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxviii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxix) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxx) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxiii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxiv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxvi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxvii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxviii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xxxix) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xl) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xli) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xlii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xliii) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xliv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xlv) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xlvi) is the substituentdescribed above.

The compound wherein the R¹ in the formula (xlvii) is the substituentdescribed above.

The arthropod pests against which the present compound has controlactivity may include, for example, insect pests and acarine pests.Specific examples are listed below:

-   -   Hemiptera: Delphacidae such as Laodelphax striatellus,        Nilaparvata lugens, and Sogatella furcifera; Deltocephalidae        such as Nephotettix cincticeps and Empoasca onukii; Aphididae        such as Aphis gossypii and Myzus persicae; Pentatomidae;        Aleyrodidae such as Trialeurodes vaporariorum, Bemisia tabaci,        and Bemisia argentifolii; Coccidae; Tingidae; Psyllidae;    -   Lepidoptera: Pyralidae such as Chilo suppressalis,        Cnaphalocrocis medinalis, Ostrinia nubilalis, and Parapediasia        teterrella; Noctuidae such as Spodoptera litura, Spodoptera        exigua, Pseudaletia separata, Mamestra brassicae, Agrotis        ipsilon, Thoricoplusia spp., Heliothis spp., Helicoverpa spp.,        and Earias spp.; Pieridae such as Pieris rapae crucivora;        Tortricidae such as Adoxophyes orana fasciata, Grapholita        molesta, and Cydia pomonella; Carposinidae such as Carposina        niponensis; Lyonetiidae such as Lyonetia clerkella;        Gracillariidae such as Phyllonorycter ringoniella;        Phyllocnistidae such as Phyllocnistis citrella; Yponomeutidae        such as Plutela xylostella; Gelechiidae such as Pectinophora        gossypiella; Arctiidae; Tineidae;    -   Diptera: Calicidae such as Culexpipienspallens, Culex        tritaeniorhynchus, and Culex quinquefasciatus; Aedes spp. such        as Aedes aegypti and Aedes albopictus; Anopheles spp. such as        Anopheles sinensis; Chironomidae; Muscidae such as Musca        domestica and Muscina stabulans; Calliphoridae; Sarcophagidae;        Fanniidae; Anthomyiidae such as Delia platura and Delia antiqua;        Tephritidae; Drosophilidae; Psychodidae; Tabanidae; Simuliidae;        Stomoxyidae; Agromyzidae;    -   Coleoptera: Diabrotica spp. such as Diabrotica virgifera        virgifera and Diabrotica undecimpunctata howardi; Scarabaeidae        such as Anomala cuprea and Anomala rufocuprea; Curculionidae        such as Sitophilus zeamais, Lissorhoptrus oryzophilus, and        Callosobruchuys chienensis; Tenebrionidae such as Tenebrio        molitor and Tribolium castaneum; Chrysomelidae such as Oulema        oryzae, Aulacophora femoralis, Phyllotreta striolata, and        Leptinotarsa decemlineata; Anobiidae; Epilachna spp. such as        Epilachna vigintioctopunctata; Lyctidae; Bostrychidae;        Cerambycidae; Paederus fuscipes;    -   Thysanoptera: Thripidae spp. including Thrips spp. such as        Thripspalmi, Frankliniella spp. such as Frankliniella        occidentalis, and Sciltothrips spp. such as Sciltothrips        dorsalis; Phlaeothripidae spp.;

Hymenoptera: Tenthredinidae; Formicidae; Vespidae;

Dictyoptera: Periplaneta spp.; Blatta spp.;

Orthoptera: Acrididae; Gryllotalpidae;

Aphaniptera: Pulex irritans;

Anoplura: Pediculus humanus;

Isoptera: Termitidae;

Acarina: Tetranychidae.

The arthropod controlling composition of the present invention may bethe present compound itself. The arthropod controlling composition ofthe present invention is usually produced by mixing the presentcompound, and a solid carrier, a liquid carrier, a gaseous carrierand/or bait (material for poison bait), if necessary, adding asurfactant and other adjuvant, and formulating to an oil solution, anemulsifiable concentrate, a flowable formulation, a wettable powder, agranule, a powder, a poison bait, a microcapsule and the like. In thepesticide composition of the present invention, the present compound isusually contained in an amount of 0.1% to 95% by weight.

The solid carrier for formulation includes, for example, a fine powerand a granule of clays (e.g., kaolin clay, diatomite, bentonite,Fubasami clay, acid clay, etc.), synthetic hydrated silicon oxide, talc,ceramic, other inorganic minerals (e.g., sericite, quartz, sulfur,activated carbon, calcium carbonate, hydrated silica) or chemicalfertilizers (e.g., ammonium sulfate, ammonium phosphate, ammoniumnitrate, ammonium chloride, urea). The liquid carrier for formulationincludes, for example, water, alcohols (e.g., methanol, ethanol,2-propyl alcohol, ethylene glycol), ketones (e.g., acetone, methyl ethylketone, methyl isobutyl ketone, cyclohexanone), aromatic hydrocarbons(e.g., toluene, xylene, ethylbenzen, methylnaphthalene), aliphatichydrocarbons (e.g., hexane, cyclohexane, kerosine, light oil), esters(e.g., ethyl acetate, butyl acetate), nitriles (e.g., acetonitrile,isobutyronitrile), ethers (e.g., ethylene glycol dimethyl ether,diisopropyl ether, 1,4-dioxane, tetrahydrofuran), acid amides (e.g.,N,N-dimethylformamide, N,N-dimethylacetamide), halogenated hydrocarbons(e.g., dichloromethane, trichloroethane), dimethylsulfoxide, vegetableoils (e.g., soy bean oil, cotton seed oil).

The gaseous carrier for formulation includes, for example,fluorocarbons, butane gas, liquefied petroleum gas (LPG), dimethylether, carbon dioxide and the like.

The surfactant for formulation includes, for example, alkyl sulfatesalts, alkylsulfonic acid salts, alkylarylsulfonic acid salts, alkylaryl ethers and their polyoxyethylene derivatives, polyethylene glycolethers, polyhydric alcohol esters, and sugar alcohol derivatives.

The other adjuvant for formulation includes, for example, binders,dispersants and stabilizers, and specifically for example, casein,gelatin, polysaccharides (e.g., starch, gum arabic, cellulosederivatives, alginic acid), lignin derivatives, bentonite, sugars,synthetic water-soluble polymers (e.g., polyvinyl alcohol,polyvinylpyrrolidone, polyacrylic acid), PAP (isopropyl acid phosphate),BHT (2,6-di-t-butyl-4-methylphenol), BHA (a mixture of2-t-butyl-4-methoxyphenol and 3-t-butyl-4-methoxyphenol), mineral oils,fatty acids, and fatty acid esters.

A base material for the poison bait includes, for example, grainpowders, vegetable oils, sugars, and crystalline cellulose, and further,if necessary, antioxidants such as dibutylhydroxytoluene andnordihydroguaiaretic acid, preservatives such as dehydroacetic acid,agents for preventing children and pets from erroneously eating such ashot pepper powder, and pest-attractive flavors such as cheese flavor,onion flavor and peanut oil may be added to the base material.

The arthropod controlling composition is used by applying the arthropodcontrolling composition to pests directly and/or habitats of pests(e.g., nest, plant, soil). In the case of controlling the arthropod pestwhich is parasitic on a cultivating plant, for example, the arthropodcontrolling composition of the present invention is sprayed onto theupper side of the cultivating plant, pouring into the vicinities of aroot of the cultivation plant.

When the pesticide composition of the present invention is used for acontrol of pests in agriculture and forestry, the application amount isusually 0.1 to 10,000 g as an active ingredient per 1,000 m². Theemulsifiable concentrates, flowables, wettable powders and microcapsuleformulations are usually applied after dilution with water to have anactive ingredient concentration of 10 to 10,000 ppm, while oil solution,powders and granules are usually applied as such.

When the pesticide composition of the present invention is used for acontrol of epidemic, the application amount is usually 0.001 to 100 mgas an active ingredient per 1 m² in case of application for plane, and0.001 to 10 mg as an active ingredient per 1 m³ in case of applicationfor open space surface. The emulsifiable concentrates, wettable powdersand flowables are usually applied after dilution with water to have anactive ingredient concentration of 0.01 to 100,000 ppm, while oilsolutions, aerosols, smoking agents and poison baits are usually appliedas such.

The pesticide composition of the present invention can also be used inadmixture or combination with other insecticides, nematocides,acaricides, fungicides, herbicides, plant growth regulators, synergists,fertilizers, soil conditioners, animal feeds, and the like.

The active ingredients of such other insecticide and acaricide include,for example, organophosphorus compounds such as fenitrothion, fenthion,pyridaphenthion, diazinon, chlorpyrifos, chlorpyrifos-methyl, acephate,methidathion, disulfoton, DDVP, sulprofos, profenofos, cyanophos,dioxabenzofos, dimethoate, phenthoate, malathion, trichlorfon,azinphos-methyl, monocrotophos, dicrotophos, ethion, and fosthiazate;carbamate compounds such as BPMC, benfuracarb, propoxur, carbosulfan,carbaryl, methomyl, ethiofencarb, aldicarb, oxamyl, fenothiocarb, andthiodicarb; pyrethroid compounds such as etofenprox, fenvalerate,esfenvalerate, fenpropathrin, cypermethrin, alfa-cypermethrin,zeta-cypermethrin, permethrin, cyhalothrin, lambda-cyhalothrin,cyfluthrin, beta-cyfluthrin, deltamethrin, cycloprothrin,tau-fluvalinate, flucythrinate, bifenthrin, acrinathrin, tralomethrin,silafluofen, and halfenprox;

-   neonicotinoid compounds such as acetamiprid, thiamethoxam, and    thiacloprid; benzoylphenylurea compounds such as chlorfluazuron,    teflubenzuron, flufenoxuron, and lufenuron; benzoylhydrazide    compounds such as tebufenozide, chromafenozide, methoxyfenozide and    halofenozide; thiadiazine derivatives such as buprofezin;    nereistoxin derivatives such as cartap, thiocyclam, and bensultap;    chlorinated hydrocarbon compounds such as endosulfan, gamma-BHC, and    1,1-bis(chlorophenyl)-2,2,2-trichloroethanol; formamidine    derivatives such as amitraz and chlordimeform; thiourea derivatives    such as diafenthiuron; phenylpyrazole derivatives such as ethiprole,    and acetoprole; chlorfenapyr; pymetrozine; spinosad; indoxacarb;    bromopropylate; tetradifon; chinomethionat; propargite; fenbutatin    oxide; hexythiazox; etoxazole; clofentezine; pyridaben; pyridalyl;    fenpyroximate; tebufenpyrad; pyrimidifen; fenazaquin; acequinocyl;    bifenazate; spirodiclofen; spiromesifen; milbemectin; avermectin;    emamectin benzoate; azadirachtin; polynactin complexes such as    tetranactin, dinactin, and trinactin; and the like.

The present invention will be further illustrated by the followingproduction examples, formulation examples, and test examples; however,the present invention is not limited to these examples. In the followingproduction examples, the data of ¹H-NMR were measured in a solvent ofdeuterium chloroform with tetramethylsilane as the internal standard.

Production Examples of the present compounds are exemplified.

PRODUCTION EXAMPLE 1

Into 11 ml of N,N-dimethylformamide were dissolved 190 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 123 mg of benzyl alcohol, 59mg of sodium hydride (60% in oil) was added thereto under ice-cooling,and the reaction mixture was stirred for 0.5 hour under ice-cooling andfor 4.5 hours at room temperature. The reaction mixture was added tosaturated ammonium chloride aqueous solution, and extracted with t-butylmethyl ether. The organic layer was concentrated, and the residueobtained was subjected to silica gel column chromatography to give 190mg of 5-benzyloxy-3-methylthio-1,2,4-thiadiazole (hereinafter, referredto as the present compound (1)).

¹H-NMR: 7.43-7.38 (m, 5H), 5.49 (s, 2H), 2.62 (s, 3H)

PRODUCTION EXAMPLE 2

Into 2 ml of N,N-dimethylformamide was dissolved 215 mg of2-chlorobenzyl alcohol, 59 mg of sodium hydride (60% in oil) was addedthereto under ice-cooling. After stirring for 30 minutes, a solution of250 mg of 5-chloro-3-methylthio-1,2,4-thiadiazole in 2 ml ofN,N-dimethylformamide was added dropwise into the mixture and thereaction mixture was stirred for 0.5 hour under ice-cooling and for 2hours at room temperature. The reaction mixture was added to saturatedsodium chloride aqueous solution, and extracted with t-butyl methylether. The organic layer was concentrated, and the residue obtained wassubjected to silica gel column chromatography to give 188 mg of5-(2-chlorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (2)).

¹H-NMR: 7.53-7.29 (m, 4H), 5.61 (s, 2H), 2.62 (s, 3H)

PRODUCTION EXAMPLE 3

By using 215 mg of 3-chlorobenzyl alcohol instead of 2-chlorobenzylalcohol according to Production Example 2 was obtained 190 mg of5-(3-chlorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (3)).

¹H-NMR: 7.45-7.30 (m, 4H), 5.47 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 4

Into 2 ml of N,N-dimethylformamide were dissolved 150 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 154 mg of 4-chlorobenzylalcohol, 43 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 0.5 hour underice-cooling and for 4 hours at room temperature. The reaction mixturewas added to saturated sodium chloride aqueous solution, and extractedwith t-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 170 mg of 5-(4-chlorobenzyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (4)).

¹H-NMR: 7.37 (s, 4H), 5.46 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 5

By using 264 mg of 2-trifluoromethybenzyl alcohol instead of2-chlorobenzyl alcohol according to Production Example 2 was obtained203 mg of 5-(2-trifluoromethylbenzyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (5)).

¹H-NMR: 7.76-7.49 (m, 4H), 5.68 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 6

By using 264 mg of 3-trifluoromethybenzyl alcohol instead of2-chlorobenzyl alcohol according to Production Example 2 was obtained 93mg of 5-(3-trifluoromethylbenzyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (6)).

¹H-NMR: 7.73-7.50 (m, 4H), 5.55 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 7

By using 264 mg of 4-trifluoromethybenzyl alcohol instead of2-chlorobenzyl alcohol according to Production Example 2 was obtained 61mg of 5-(4-trifluoromethylbenzyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (7)).

¹H-NMR: 7.67 (d, 2H), 7.56 (d, 2H), 5.56 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 8

By using 131 mg of 4-methylbenzyl alcohol instead of 4-chlorobenzylalcohol according to Production Example 4 was obtained 85 mg of5-(4-methylbenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (8)).

¹H-NMR: 7.33 (d, 2H), 7.21 (d, 2H), 5.44 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 9

By using 246 mg of 4-tert-butylbenzyl alcohol instead of 2-chlorobenzylalcohol according to Production Example 2 was obtained 264 mg of5-(4-tert-butylbenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (9)).

¹H-NMR: 7.44 (d, 2H), 7.38 (d, 2H), 5.46 (s, 2H), 2.68 (s, 3H) 1.34 (s,9H)

PRODUCTION EXAMPLE 10

By using 207 mg of 4-methoxybenzyl alcohol instead of 2-chlorobenzylalcohol according to Production Example 2 was obtained 179 mg of5-(4-methoxybenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (10)).

¹H-NMR: 7.49 (d, 2H), 7.92 (d, 2H), 5.44 (s, 2H), 3.82 (s, 3H) 2.61 (s,3H)

PRODUCTION EXAMPLE 11

By using 231 mg of 4-methyothiobenzyl alcohol instead of 2-chlorobenzylalcohol according to Production Example 2 was obtained 239 mg of5-(4-methythiobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (11)).

¹H-NMR: 7.36 (d, 2H), 7.24 (d, 2H), 5.42 (s, 2H), 2.62 (s, 3H)2.49 (s,3H)

PRODUCTION EXAMPLE 12

Into 3 ml of N,N-dimethylformamide were dissolved 334 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 4-fluorobenzyl alcohol, 84mg of sodium hydride (60% in oil) was added thereto under ice-cooling,and the reaction mixture was stirred for 1 hour under ice-cooling andfor 4 hours at room temperature. The reaction mixture was added tosaturated sodium chloride aqueous solution, and extracted with t-butylmethyl ether. The organic layer was concentrated, and the residueobtained was subjected to silica gel column chromatography to give 357mg of 5-(4-fluorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (12)).

¹H-NMR: 7.43 (m, 2H), 7.09 (m, 2H), 5.46 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 13

By using 374 mg of 4-bromobenzyl alcohol instead of 4-fluorobenzylalcohol according to Production Example 12 was obtained 500 mg of5-(4-bromobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (13)).

¹H-NMR: 7.53 (d, 2H), 7.32 (d, 2H), 5.44 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 14

By using 468 mg of 4-iodobenzyl alcohol instead of 4-fluorobenzylalcohol according to Production Example 12 was obtained 440 mg of5-(4-iodobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (14)).

¹H-NMR: 7.74 (d, 2H), 7.19 (d, 2H), 5.43 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 15

By using 384 mg of 4-trifluoromethoxybenzyl alcohol instead of4-fluorobenzyl alcohol according to Production Example 12 was obtained480 mg of5-(4-trifluoromethoxybenzyloxy)-3-methylthio-1,2,4-thiadiazole.5-(4-trifluoromethoxybenzyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (15)).

¹H-NMR: 7.48 (d, 2H), 7.23 (d, 2H), 5.49 (d, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 16

By using 216 mg of 2,6-difluorobenzyl alcohol instead of 4-chlorobenzylalcohol according to Production Example 2 was obtained 254 mg of5-(2,6-difluorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (16)).

¹H-NMR: 7.44-7.32 (m, 1H), 6.99-6.92 (m, 2H), 5.60 (s, 2H), 2.63 (s, 3H)

PRODUCTION EXAMPLE 17

By using 216 mg of 3,5-difluorobenzyl alcohol instead of 4-chlorobenzylalcohol according to Production Example 2 was obtained 108 mg of5-(3,5-difluorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (17)).

¹H-NMR: 6.96 (m, 2H), 6.81 (m, 1H), 5.47 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 18

By using 266 mg of 3,4-dichlorobenzyl alcohol instead of 4-chlorobenzylalcohol according to Production Example 2 was obtained 241 mg of5-(3,4-dichlorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (18)).

¹H-NMR: 7.55 (s, 1H), 7.48 (d, 1H), 7.28 (d, 1H), 5.44 (s, 2H), 2.61 (s,3H)

PRODUCTION EXAMPLE 19

Into 2 ml of N,N-dimethylformamide was dissolved 218 mg of2-pyridylmethanol, 84 mg of sodium hydride (60% in oil) was addedthereto under ice-cooling. After stirring for 15 minutes, a solution of334 mg of 5-chloro-3-methylthio-1,2,4-thiadiazole in 2 ml ofN,N-dimethylformamide was added dropwise into the mixture and thereaction mixture was stirred for 0.5 hour under ice-cooling and for 2hours at room temperature. The reaction mixture was added to saturatedsodium chloride aqueous solution, and extracted with t-butyl methylether. The organic layer was concentrated, and the residue obtained wassubjected to silica gel column chromatography to give 30 mg of5-(2-pyridylmethyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (19)).

¹H-NMR: 8.64 (d, 1H), 7.77 (t, 1H), 7.46 (d, 1H), 7.28 (t, 1H), 5.60 (s,2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 20

Into 2 ml of N,N-dimethylformamide were dissolved 100 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 78 mg of 3-pyridinemethanol,78 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 0.5 hour underice-cooling and for 1 hours at room temperature. The reaction mixturewas added to saturated ammonium chloride aqueous solution, and extractedwith t-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 88 mg of 5-(3-pyridylmethyl)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (20)).

¹H-NMR: 8.72 (s, 1H), 8.64 (d, 1H), 7.81 (d, 1H), 7.35 (t, 1H), 5.53 (s,2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 21

Into 2.5 ml of N,N-dimethylformamide were dissolved 200 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 207 mg of4-chloro-3-pyridylmethyl alcohol, 59 mg of sodium hydride (60% in oil)was added thereto under ice-cooling, and the reaction mixture wasstirred for 0.5 hour under ice-cooling and for 1 hour at roomtemperature. The reaction mixture was added to saturated ammoniumchloride aqueous solution, and extracted with t-butyl methyl ether. Theorganic layer was concentrated, and the residue obtained was subjectedto silica gel column chromatography to give 170 mg of5-(6-chloro-3-pyridyl)methyloxy-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (21)).

¹H-NMR: 8.50 (d, 1H), 7.77 (dd, 1H), 7.38 (d, 1H), 5.50 (s, 2H), 2.61(s, 3H)

PRODUCTION EXAMPLE 22

By using 176 mg of 1-phenylethanol instead of 6-chloro-3-pyridylmethylalcohol according to Production Example 21 was obtained 190 mg of5-(1-phenylethoxy)-3-methylthio-1,2,4-thiadiazole (hereinafter, referredto as the present compound (22)).

¹H-NMR: 7.44-7.29 (m, 5H), 5.99 (q, 1H), 2.58 (s, 3H), 1.74 (d, 3H)

PRODUCTION EXAMPLE 23

By using 131 mg of 2-phenylethanol instead of benzyl alcohol accordingto Production Example 4 was obtained 160 mg of5-(2-phenylethoxy)-3-methylthio-1,2,4-thiadiazole (hereinafter, referredto as the present compound (23)).

¹H-NMR: 7.36-7.23 (m, 5H), 4.67 (t, 2H), 3.13 (t, 2H), 2.60 (s, 3H)

PRODUCTION EXAMPLE 24

By using 246 mg of 2-pyridyl-2-ethanol instead of 2-pyridylmethanolaccording to Production Example 19 was obtained 45 mg of5-(2-pyridyl-2-ethyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (24)).

¹H-NMR: 8.56 (d, 1H), 7.63 (t, 1H), 7.17 (m, 2H), 4.88 (t, 2H), 3.31 (t,2H), 2.60 (s, 3H)

PRODUCTION EXAMPLE 25

By using 196 mg of 3-phenylpropanol instead of 6-chloro-3-pyridylmethylalcohol according to Production Example 21 was obtained 210 mg of5-(3-phenylpropyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (25)).

¹H-NMR: 7.30-7.18 (m, 5H), 4.47 (t, 2H), 2.77 (t, 2H), 2.60 (s, 3H),2.15 (m, 2H)

PRODUCTION EXAMPLE 26

Into 4 ml of N,N-dimethylformamide were dissolved 334 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 3-nitrobenzyl alcohol, 331mg of potassium carbonate was added thereto under, and the reactionmixture was stirred for 4 hours at room temperature. The reactionmixture was added to saturated sodium chloride aqueous solution, andextracted with t-butyl methyl ether. The organic layer was concentrated,and the residue obtained was subjected to silica gel columnchromatography to give 320 mg of5-(3-nitrobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (26)).

¹H-NMR: 8.33 (s, 1H), 8.24 (d, 1H), 7.79 (d, 1H), 7.60 (t, 1H), 5.60 (s,2H), 2.62 (s, 3H)

PRODUCTION EXAMPLE 27

By using 337 mg of 4-nitrobenzyl alcohol instead of 3-nitrobenzylalcohol according to Production Example 26 was obtained 36 mg of5-(4-nitrobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (27)).

¹H-NMR: 8.27 (d, 2H), 7.62 (d, 2H), 5.61 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 28

Into 4 ml of N,N-dimethylformamide were dissolved 334 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 389 mg of 3,5-dichlorobenzylalcohol, 96 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 0.5 hour underice-cooling and for 4 hours at room temperature. The reaction mixturewas added to saturated sodium chloride aqueous solution, and extractedwith t-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 380 mg of 5-(3,5-dichlorobenzyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (28)).

¹H-NMR: 7.37 (s, 1H), 7.33 (s, 2H), 5.44 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 29

By using 389 mg of 2,4-dichlorobenzyl alcohol instead of3,5-dichlorobenzyl alcohol according to Production Example 28 wasobtained 370 mg of5-(2,4-dichlorobenzyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (29)).

¹H-NMR: 7.46 (d, 2H), 7.29 (d, 1H), 5.56 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 30

Into 4 ml of N,N-dimethylformamide were dissolved 193 mg of5-chloro-3-allylthio-1,2,4-thiadiazole and 108 mg of benzyl alcohol, 48mg of sodium hydride (60% in oil) was added thereto under ice-cooling,and the reaction mixture was stirred for 1 hour under ice-cooling. Thereaction mixture was added to saturated sodium chloride aqueoussolution, and extracted with t-butyl methyl ether. The organic layer wasconcentrated, and the residue obtained was subjected to silica gelcolumn chromatography to give 240 mg of5-benzyloxy-3-allylthio-1,2,4-thiadiazole (hereinafter, referred to asthe present compound (30)).

¹H-NMR: 7.51-7.28 (m, 5H), 5.99 (m, 1H), 5.49 (s, 2H), 5.33 (d, 1H),5.16 (d, 1H), 3.84 (d, 2H)

PRODUCTION EXAMPLE 31

Into 3 ml of N,N-dimethylformamide were dissolved 243 mg of5-chloro-3-benzylthio-1,2,4-thiadiazole and 108 mg of benzyl alcohol, 48mg of sodium hydride (60% in oil) was added thereto under ice-cooling,and the reaction mixture was stirred for 1 hour under ice-cooling andfor 17 hours at room temperature. The reaction mixture was added tosaturated sodium chloride aqueous solution, and extracted with t-butylmethyl ether. The organic layer was concentrated, and the residueobtained was subjected to silica gel column chromatography to give 146mg of 5-benzyloxy-3-benzylthio-1,2,4-thiadiazole (hereinafter, referredto as the present compound (31)).

¹H-NMR: 7.42-7.25 (m, 10H), 5.48 (s, 2H), 4.42 (s, 2H)

PRODUCTION EXAMPLE 32

Into 3 ml of N,N-dimethylformamide were dissolved 416 mg of5-chloro-3-(4-chlorobenzylthio)-1,2,4-thiadiazole and 162 mg of benzylalcohol, 48 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 15 minutes underice-cooling and for 1 hour at room temperature. The reaction mixture wasadded to saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 400 mg of 5-benzyloxy-3-(4-chlorobenzyl)thio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (32)).

¹H-NMR: 7.43-7.26 (m, 9H), 5.48 (s, 2H), 4.37 (s, 2H)

PRODUCTION EXAMPLE 33

Into 2 ml of N,N-dimethylformamide were dissolved 200 mg of5-chloro-3-(4-methoxybenzyl)thio-1,2,4-thiadiazole and 87 mg of benzylalcohol, 35 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 1 hour underice-cooling and for 4 hours at room temperature. The reaction mixturewas added to saturated sodium chloride aqueous solution, and extractedwith t-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 165 mg of 5-benzyloxy-3-(4-methoxybenzyl)thio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (33)).

¹H-NMR: 7.51-7.31 (m, 7H), 6.83 (d, 2H), 5.48 (s, 2H), 4.38 (s, 2H),3.79 (s, 3H)

PRODUCTION EXAMPLE 34

Into 4 g of N,N-dimethylformamide was dissolved 218 mg of4-pyridinemethanol, 96 mg of sodium hydride (60% in oil) was addedthereto at room temperature. After stirring for 30 minutes, a solutionof 334 mg of 5-chloro-3-methylthio-1,2,4-thiadiazole in 1 g ofN,N-dimethylformamide was added dropwise into the mixture and thereaction mixture was stirred for 4 hours at room temperature. Thereaction mixture was added to saturated sodium chloride aqueoussolution, and extracted with t-butyl methyl ether. The organic layer wasconcentrated, and the residue obtained was subjected to silica gelcolumn chromatography to give 260 mg of5-(4-pyridylmethyloxy)-3-methylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (34)).

¹H-NMR: 8.65 (d, 2H), 7.33 (d, 2H), 5.53 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 35

Into 3 g of N,N-dimethylformamide were dissolved 251 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 188 mg of6-chloro-2-pyridylmethyl alcohol, 72 mg of sodium hydride (60% in oil)was added thereto at room temperature, and the reaction mixture wasstirred for 30 minutes. The reaction mixture was added to saturatedsodium chloride aqueous solution, and extracted with t-butyl methylether. The organic layer was concentrated, and the residue obtained wassubjected to silica gel column chromatography to give 44 mg of5-(6-chloro-2-pyridylmethyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (35)).

¹H-NMR: 7.71 (t, 1H), 7.38 (d, 1H), 7.30 (d, 1H), 5.55 (s, 2H), 2.60 (s,3H)

PRODUCTION EXAMPLE 36

Into 3.6 g of N,N-dimethylformamide were dissolved 304 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 200 mg of 2-pyrimidylmethylalcohol, 87 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 15 minutes. Afterstirring for 1.5 hour at room temperature, the reaction mixture wasadded to saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 278 mg of 5-(2-pyrimidylmethyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (36)).

¹H-NMR: 8.78 (d, 2H), 7.27 (t, 1H), 5.73 (s, 2H), 2.59 (s, 3H)

PRODUCTION EXAMPLE 37

Into 4 g of N,N-dimethylformamide were dissolved 304 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 200 mg of 5-pyrimidylmethylalcohol, 97 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 30 minutes. Afterstirring for 5 hours at room temperature, the reaction mixture was addedto saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 210 mg of 5-(5-pyrimidylmethyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (37)).

¹H-NMR: 9.25 (s, 1H), 8.88 (s, 2H), 7.27 (s, 2H), 2.61 (s, 3H)

PRODUCTION EXAMPLE 38

Into 2 g of N,N-dimethylformamide were dissolved 219 mg of5-chloro-3-benzylthio-1,2,4-thiadiazole and 200 mg of 5-pyrimidylmethylalcohol, 44 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 30 minutes. Afterstirring for 5 hours at room temperature, the reaction mixture was addedto saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 130 mg of 5-(5-pyrimidylmethyloxy)-3-benzylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (38)).

H-NMR: 9.25 (s, 1H), 8.86 (s, 2H), 7.43-7.24 (m, 5H), 5.53 (s, 2H), 4.41(s, 2H)

PRODUCTION EXAMPLE 39

Into 4 g of N,N-dimethylformamide were dissolved 304 mg of5-chloro-3-methylthio-1,2,4-thiadiazole and 200 mg of 4-pyrimidylmethylalcohol, 87 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 15 minutes. Afterstirring for 2 hours at room temperature, the reaction mixture was addedto saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 210 mg of 5-(4-pyrimidylmethyloxy)-3-methylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (39)).

¹H-NMR: 9.21 (s, 1H), 8.78 (d, 1H), 7.45 (d, 1H), 5.60 (s, 2H), 2.60 (s,3H)

PRODUCTION EXAMPLE 40

By using 219 mg of 5-chloro-3-benzylthio-1,2,4-thiadiazole instead of5-chloro-3-methylthio-1,2,4-thiadiazole according to Production Example39 was obtained 110 mg of5-(4-pyrimidylmethyloxy)-3-benzylthio-1,2,4-thiadiazole (hereinafter,referred to as the present compound (40)).

¹H-NMR: 9.21 (s, 1H), 8.77 (d, 1H), 7.44-7.23 (m, 6H), 5.59 (s, 2H),4.39 (s, 2H)

PRODUCTION EXAMPLE 41

By using 252 mg of 5-chloro-3-(4-chlorobenzylthio)-1,2,4-thiadiazoleinstead of 5-chloro-3-methylthio-1,2,4-thiadiazole according toProduction Example 40 was obtained 127 mg of5-(4-pyrimidylmethyloxy)-3-(4-chlorobenzyl)thio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (41)).

¹H-NMR: 9.21 (s, 1H), 8.78 (d, 1H), 7.43-7.24 (m, 5H), 5.58 (s, 2H),4.34 (s, 2H)

PRODUCTION EXAMPLE 42

Into 3 g of N,N-dimethylformamide were dissolved 300 mg of5-chloro-3-ethoxymethylthio-1,2,4-thiadiazole and 153 mg of benzylalcohol, 68 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 15 minutes. Afterstirring for 2 hours at room temperature, the reaction mixture was addedto saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 210 mg of 5-benzylloxy-3-ethoxymethylthio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (42)).

¹H-NMR: 7.46-7.36 (m, 5H), 5.49 (s, 2H), 5.40 (s, 2H), 3.67 (q, 2H),1.24 (t, 3H)

PRODUCTION EXAMPLE 43

Into 3 g of N,N-dimethylformamide were dissolved 350 mg of5-chloro-3-benzyloxymethylthio-1,2,4-thiadiazole and 153 mg of benzylalcohol, 68 mg of sodium hydride (60% in oil) was added thereto underice-cooling, and the reaction mixture was stirred for 30 minutes. Afterstirring for 2 hours at room temperature, the reaction mixture was addedto saturated sodium chloride aqueous solution, and extracted witht-butyl methyl ether. The organic layer was concentrated, and theresidue obtained was subjected to silica gel column chromatography togive 260 mg of 5-bezyloxy-3-benzyloxymethythio-1,2,4-thiadiazole(hereinafter, referred to as the present compound (43)).

¹H-NMR: 7.45-7.25 (m, 10H), 5.49 (s, 2H), 5.43 (s, 2H), 4.71 (s, 2H)

PRODUCTION EXAMPLE 44

Into 1.5 g of acetic anhydride were added 620 mg of 2,6-lutidine and 500mg of 5-benzyloxy-3-methylsulfinyl-1,2,4-thiadiazole under ice-cooling.After stirring for 15 hours at room temperature, the reaction mixturewas added to saturated sodium hydrogen carbonate aqueous solution, andextracted with t-butyl methyl ether. The organic layer was concentrated,and the residue obtained was subjected to silica gel columnchromatography to give 376 mg of5-bezyloxy-3-acetoxymethythio-1,2,4-thiadiazole (hereinafter, referredto as the present compound (44)).

¹H-NMR: 7.46-7.36 (m, 5H), 5.77 (s, 2H), 5.50 (s, 2H), 2.11 (s, 3H)

Next, the production of the intermediate of the present compound isdescribed as Reference Production Examples.

REFERENCE PRODUCTION EXAMPLE 1

Into the mixture of 20 ml of toluene and 10 ml of water were added 2.53g of 4-methoxybenzylisothiourea hydrogen chloride, 2.03 g ofperchloromethyl mercaptan, and 50 mg of benzyltriethylammonium chloride,and a solution of 1.74 g of sodium hydroxide in 10 ml of water was addeddropwise to the mixture at about 0° C. over 4 hours. After the addition,the mixture was stirred for 1 hour at room temperature. Into thereaction mixture was added t-butyl methyl ether, and extracted. Theorganic layer was dried over anhydrous sodium sulfate, concentrated, andthe residue obtained was subjected to silica gel column chromatographyto give 5.38 g of 5-chloro-3-(4-methoxybenzyl)thio-1,2,4-thiadiazole.

¹H-NMR: 7.35 (d, 2H), 6.85 (d, 2H), 4.41 (s, 2H), 3.79 (s, 3H)

REFERENCE PRODUCTION EXAMPLE 2

Into the mixture of 35 ml of water and 70 ml of dichloromethane wereadded 12.2 g of ethoxymethylisothiourea hydrogen chloride and 13.2 g ofperchloromethyl mercaptan, and a solution of 11.4 g of sodium hydroxidein 35 ml of water was added dropwise to the mixture at about 0° C. over1.5 hour. After the addition, the mixture was stirred for 1 hour at roomtemperature. Into the reaction mixture was added chloroform, andextracted. The organic layer was dried over anhydrous sodium sulfate,concentrated, and the residue obtained was subjected to silica gelcolumn chromatography to give 5.22 g of5-chloro-3-ethoxymethylthio-1,2,4-thiadiazole.5-chloro-3-ethoxymethylthio-1,2,4-thiadiazole

¹H-NMR: 5.43 (s, 2H), 3.68 (q, 2H), 1.26 (t, 3H)

REFERENCE PRODUCTION EXAMPLE 3

Into the mixture of 25 ml of water and 50 ml of dichloromethane wereadded 11.3 g of benzyloxymethylisothiourea hydrogen chloride and 9.02 gof perchloromethyl mercaptan, and a solution of 7.76 g of sodiumhydroxide in 25 ml of water was added dropwise to the mixture at about0° C. over 1.5 hour. After the addition, the mixture was stirred for 1hour at room temperature. Into the reaction mixture was addedchloroform, and extracted. The organic layer was dried over anhydroussodium sulfate, concentrated, and the residue obtained was subjected tosilica gel column chromatography to give 3.51 g of5-chloro-3-benzyloxymethylthio-1,2,4-thiadiazole.

¹H-NMR: 7.36-7.28 (m, 5H), 5.45 (s, 2H), 4.69 (s, 2H)

REFERENCE PRODUCTION EXAMPLE 4

Into 12 ml of chloroform was dissolved 1.39 g of5-benzyloxy-3-methylthio-1,2,4-thiadiazole, and metachloroperbenzoicacid (>70%) was slowly added to the mixture under ice-cooling. Afterstirring for 1 hour, the compound of low-polarity from the reactionmixture was detected by thin layer chromatography. The reaction mixturewas poured into a saturated sodium sulfite aqueous solution, andseparated. The organic layer was washed with sodium hydrogen carbonateaqueous solution, dried over anhydrous sodium sulfate, concentrated togive 1.4 g of 5-benzyloxy-3-methylsulfinyl-1,2,4-thiadiazole.

Next, Formulation Examples will be shown below. Parts are by weight.

FORMULATION EXAMPLE 1

Each 9 parts of the present compounds (1) to (44) were dissolved in 37.5parts of xylene and 37.5 parts of dimethylformamide, and to this wasadded 10 parts of polyoxyethylene styrylphenyl ether and 6 parts ofcalcium dodecylbenzenesulfonate, and they were mixed thoroughly toobtain an emulsifiable concentrate.

FORMULATION EXAMPLE 2

Each 9 parts of the present compounds (1) to (44) were dissolved in amixture of 4 parts of sodium laureate, 2 parts of calciumligninsulfonate, 20 parts of a synthetic water-containing silicon oxidefine powder, and 65 parts of diatomaceous earth, and they were mixedthoroughly to obtain a wettable powder.

FORMULATION EXAMPLE 3

Each 3 parts of the present compounds (1) to (44) were dissolved in amixture of 5 parts of a synthetic water-containing silicon oxide finepowder, 5 parts of sodium dodecylbenzeneuslfonate, 30 parts ofbentonite, and 57 parts of clay, and they were mixed thoroughly, then,suitable amount of water was added to the mixture thereof, the resultedmixture was further stirred, granulated in a granulator, and dried underventilation to obtain a granule.

FORMULATION EXAMPLE 4

Each 4.5 parts of the present compounds (1) to (44), 1 part of asynthetic water-containing silicon oxide fine powder, 1 part of DRILESSB (manufactured by Sankyo Co., Ltd.) and 7 parts of clay were mixedthoroughly in a mortar, then, stirred to mix by a juice mixer. To theresulted mixture was added 86.5 parts of cut clay, they weresufficiently stirred to mix, to obtain a powder.

FORMULATION EXAMPLE 5

Each 10 parts of the present compounds (1) to (44), 35 parts of whitecarbon containing 50 parts of ammonium polyoxyethylene alkyl ethersulfate, and 55 parts of water were mixed and finely ground according toa wet grinding method, to obtain a formulation.

FORMULATION EXAMPLE 6

Each 0.5 part of the present compounds (1) to (44) is dissolved in 10parts of dichloromethane and mixed with 89.5 parts of Isoper M(isoparafin; trademark of Exxon chemicals), to obtain a oil solution.

FORMULATION EXAMPLE 7

An aerosol vessel is filled with each 0.5 part of the present compound(1) to (44) and 49.9 parts of Neothiozol (manufactured by Chuo KaseiCo.). The vessel is then equipped with a valve, 25 parts of dimethylether and 25 parts of liquefied petroleum gas are charged into theaerosol vessel, and the aerosol vessel is shaken and equipped with anactuator to give oil-based aerosol.

FORMULATION EXAMPLE 8

An aerosol vessel is filled with a solution of each 0.5 part of thepresent compound (1) to (44), 0.01 part of BHT, 5 parts of xylene, 3.39parts of deodorized kerosene and 1 part of an emulsifiable agent (Atmos300, trademark of Atlas Chemical Co.), and 50 parts of water. The vesselis then equipped with a valve and 40 parts of propellant (liquefiedpetroleum gas) is charged through the valve into the aerosol vesselunder pressure to give water-based aerosol.

Next, the use example of the present compound as the arthropod pestscontrolling composition is showed by a Test Example.

TEST EXAMPLE

Each formulation of the present compound (1), (3), (4), (6), (7), (8),(12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23),(24), (25), (26), (28), (30), (31), (33), (34), (35), (36), (37), (38),(42), (43) and (44) obtained according to the Formulation Example 5 wasdiluted with water so that the active ingredient concentration came to500 ppm to prepare a diluting liquid.

The seeds of cucumber were planted in polyethylene cups and grown untiltheir first foliage leaves developed, on which about 20 cotton aphids(Aphis gossypii) were made parasitic. After one day, the diluting liquidwas sprayed at the rate of 20 ml/cup onto the cucumber plants. On the6th day after the application, the number of cotton aphids was examined.As a result, the numbers of the living cotton aphids were three or less.

INDUSTRIAL APPLICABILITY

By using the present compounds, arthropod pests can be controlled.

1. A thiadiazole compound of the formula (A):

wherein R¹ represents methyl, C₃-C₇ alkenyl, C₂-C₇ alkoxyalkyl, C₂-C₇alkylthioalkyl, C₄-C₇ alkoxyalkoxyalkyl, C₄-C₇ alkylthioalkoxyalkyl,phenyl C₁-C₂ alkyl, phenyloxy C₁-C₂ alkyl, phenyl C₂-C₃ alkoxyalkyl,wherein the phenyl group or the phenyloxy group is optionallysubstituted, or the substituent of the formula (B):

wherein R³ represents C₁-C₃ alkyl, and R⁴ represents a hydrogen atom,methyl, ethyl or optionally substituted phenyl; and R² represents phenylC₁-C₄ alkyl, wherein the phenyl group is optionally substituted.
 2. Thethiadiazole compound according to claim 1, wherein the phenyl group inR² is optionally substituted with one or more selected from the groupconsisting of C₁-C₄ alkyl, C₁-C₄ haloalkyl, C₁-C₄ alkoxy, C₁-C₄alkylthio, C₁-C₄ haloalkoxy, nitro, cyano and halogen atoms.
 3. Thethiadiazole compound according to claim 1, wherein the phenyl group inR² is optionally substituted with one or more selected from the groupconsisting of C₁-C₄ alkyl, C₁-C₄ haloalkyl, C₁-C₄ alkoxy, C₁-C₄alkylthio, C₁-C₄ haloalkoxy and halogen atoms.
 4. The thiadiazolecompound according to claim 1, wherein R¹ is methyl.
 5. The thiadiazolecompound according to claim 1, wherein R¹ is C₃-C₇ alkenyl, C₂-C₇alkoxyalkyl, C₂-C₇ alkylthioalkyl, C₄-C₇ alkoxyalkoxyalkyl, or C₄-C₇alkylthioalkoxyalkyl.
 6. The thiadiazole compound according to claim 1,wherein R¹ is phenyl C₁-C₂ alkyl, phenyloxy C₁-C₂ alkyl, or phenyl C₂-C₃alkoxyalkyl, wherein the phenyl group or the phenyloxy group isoptionally substituted with one or more selected from the groupconsisting of C₁-C₄ alkyl, C₁-C₄ haloalkyl, C₁-C₄ alkoxy, C₁-C₄alkylthio, C₁-C₄ haloalkoxy, nitro, cyano and halogen atoms.
 7. Thethiadiazole compound according to claim 1, wherein R¹ is the substituentof the formula (B):

wherein R³ represents C₁-C₃ alkyl, and R⁴ represents a hydrogen atom,methyl, ethyl, or phenyl optionally substituted with one or moreselected from the group consisting of C₁-C₄ alkyl, C₁-C₄ haloalkyl,C₁-C₄ alkoxy, C₁-C₄ alkylthio, C₁-C₄ haloalkoxy, nitro, cyano andhalogen atoms.
 8. The thiadiazole compound according to claim 1, whereinR¹ is (C₁-C₆ alkoxy)methyl or (C₁-C₆ alkylthio)methyl.
 9. Thethiadiazole compound according to claim 1, wherein R¹ is benzyl,phenyloxymethyl, or benzyloxymethyl, optionally substituted with one ormore selected from the group consisting of C₁-C₄ alkyl, C₁-C₄ haloalkyl,C₁-C₄ alkoxy, C₁-C₄ alkylthio, C₁-C₄ haloalkoxy, nitro, cyano andhalogen atoms.
 10. An arthropod controlling composition containing aneffective amount of the thiadiazole compound according to claim
 1. 11. Amethod for controlling an arthropod pest comprising applying aneffective amount of the thiadiazole compound according to claim 1 to thearthropod pest or the habitats of the arthropod pest.